BMY — Bristol-Myers Squibb Company stock price and chart

BMY

Bristol-Myers Squibb CompanyStock · HealthcareS&P 500 Equal Weight 0.2% · S&P 500 0.2% · Russell 1000 0.2% · US Stock Market 0.2% · Russell 3000 0.2% · MSCI World 0.1% · MSCI ACWI 0.1%

$63.64-0.17%

as of market close, Sep 11, 2026

☾ AH — —

PeersMRNALLYUNHJNJMRKABBV

Technical analysis2

Overlay lines0

Addendum charts0

VolumeDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDD

20162019202120242026

45.050.055.060.065.070.075.00200.0M$63.64

2026-09-11

Price$63.64

MA20$60.04

MA50$54.52

Vol40.7M

What would $1,000 invested in BMY be worth today? →

BMY returns: By year · By month · By week · Trailing

Key stats

Price data

Price: $63.64
Change YTD: +21.97%
Next earnings: Oct 29, 2026
Market cap: 130B2016-09 90.1B2026-09 130B+44.2% over the window
Enterprise value: 166.2B
Shares outstanding: 2B2016-06 1.7B2026-06 2B+22.3% over the window
52W low: $42.52
52W high: $68.64
From 52W high: -7.28%
From 52W low: +49.67%
52W range: 81%
Beta: 0.23

Volume

Rel volume: 0.72×
30D volume: 9.8M
30D $ vol: 642.6M

Fundamentals

Sales (ttm): 49.2B2016-06 17.6B2026-06 49.2B+179.2% over the window
Sales/share: $24.082016-06 $10.542026-06 $24.08+128.4% over the window
EPS (ttm): $4.542016-06 $1.702026-06 $4.54+167.2% over the window
FCF (ttm): 11.4B2016-06 597M2026-06 11.4B+1816.2% over the window
FCF/share: $5.602016-06 $0.362026-06 $5.60+1467.4% over the window
Book value/share: $10.932016-06 $8.932026-06 $10.93+22.4% over the window
Net margin: 18.87%2016-06 16.3%2026-06 18.9%+15.8% over the window
ROE: 41.59%2016-06 19.2%2026-06 41.6%+116.2% over the window
ROA: 10.59%2016-06 8.7%2026-06 10.6%+21.2% over the window
Debt / equity: 1.89×2016-06 0.442026-06 1.89+327.5% over the window
Current ratio: 1.532016-06 1.562026-06 1.53-1.8% over the window

Growth (CAGR, ttm) · 10Y

Sales: +3.11%2025-06-30 → 2026-06-3047.7B → 49.2B (+3.1% total)+2.87%2023-06-30 → 2026-06-3045.2B → 49.2B (+8.8% total)+2.08%2021-06-30 → 2026-06-3044.4B → 49.2B (+10.8% total)+10.81%2016-06-30 → 2026-06-3017.6B → 49.2B (+179.2% total)
Net income: +83.92%2025-06-30 → 2026-06-305B → 9.3B (+83.8% total)+5.24%2023-06-30 → 2026-06-308B → 9.3B (+16.6% total)n/a+12.46%2016-06-30 → 2026-06-302.9B → 9.3B (+223.4% total)
FCF: -21.54%2025-06-30 → 2026-06-3014.6B → 11.4B (-21.5% total)+2.19%2023-06-30 → 2026-06-3010.7B → 11.4B (+6.7% total)-0.43%2021-06-30 → 2026-06-3011.7B → 11.4B (-2.1% total)+34.36%2016-06-30 → 2026-06-30597M → 11.4B (+1816.2% total)
Shares: +0.36%2025-06-30 → 2026-06-302B → 2B (+0.4% total)-0.75%2023-06-30 → 2026-06-302.1B → 2B (-2.2% total)-1.67%2021-06-30 → 2026-06-302.2B → 2B (-8.1% total)+2.03%2016-06-30 → 2026-06-301.7B → 2B (+22.3% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: +83.15%2025-06-30 → 2026-06-30$2.48 → $4.54 (+83.1% total)+6.56%2023-06-30 → 2026-06-30$3.75 → $4.54 (+21.0% total)n/a+10.33%2016-06-30 → 2026-06-30$1.70 → $4.54 (+167.2% total)
Sales/share: +2.74%2025-06-30 → 2026-06-30$23.44 → $24.08 (+2.7% total)+3.64%2023-06-30 → 2026-06-30$21.63 → $24.08 (+11.3% total)+3.81%2021-06-30 → 2026-06-30$19.97 → $24.08 (+20.6% total)+8.61%2016-06-30 → 2026-06-30$10.54 → $24.08 (+128.4% total)
FCF/share: -21.82%2025-06-30 → 2026-06-30$7.16 → $5.60 (-21.8% total)+2.96%2023-06-30 → 2026-06-30$5.13 → $5.60 (+9.1% total)+1.26%2021-06-30 → 2026-06-30$5.26 → $5.60 (+6.5% total)+31.68%2016-06-30 → 2026-06-30$0.36 → $5.60 (+1467.4% total)
Book value/share: +27.58%2025-06-30 → 2026-06-30$8.57 → $10.93 (+27.6% total)-10.62%2023-06-30 → 2026-06-30$15.30 → $10.93 (-28.6% total)-7.99%2021-06-30 → 2026-06-30$16.56 → $10.93 (-34.0% total)+2.04%2016-06-30 → 2026-06-30$8.93 → $10.93 (+22.4% total)
Dividend/share: +2.03%2025-06-30 → 2026-06-30$2.46 → $2.51 (+2.0% total)+3.71%2023-06-30 → 2026-06-30$2.25 → $2.51 (+11.6% total)+5.51%2021-06-30 → 2026-06-30$1.92 → $2.51 (+30.7% total)+5.21%2016-06-30 → 2026-06-30$1.51 → $2.51 (+66.2% total)
Price: +33.89%2025-09-11 → 2026-09-11$47.54 → $63.64 (+33.9% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+1.53%2023-09-11 → 2026-09-11$60.81 → $63.64 (+4.7% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+0.16%2021-09-10 → 2026-09-11$63.13 → $63.64 (+0.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+1.35%2016-09-09 → 2026-09-11$55.66 → $63.64 (+14.3% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: +40.32%2025-09-11 → 2026-09-11$45.36 → $63.64 (+40.3% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+6.42%2023-09-11 → 2026-09-11$52.80 → $63.64 (+20.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+4.35%2021-09-10 → 2026-09-11$51.44 → $63.64 (+23.7% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+4.98%2016-09-09 → 2026-09-11$39.13 → $63.64 (+62.6% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 14.0×2016-09 26.772026-09 14.00-47.7% over the window
Fwd P/E: 9.9×
P/S (ttm)Market cap ÷ TTM revenue.: 2.6×2016-09 4.882026-09 2.64-45.8% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 5.8×2016-09 5.772026-09 5.82+0.9% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 11.4×2016-09 65.782026-09 11.36-82.7% over the window
EV/EBITDA (fy): 9.9×
EV/Sales (ttm): 3.4×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 8.80%2016-06 0.7%2026-06 9.7%+1358.1% over the window
Dividend yield (fwd)Indicated forward annual dividend ÷ current price — the rate the company has announced, not what was actually paid over the past year.: 3.94%
Dividend/share (fwd): $2.51
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 2.04B ÷ 2.04B. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: -0.36%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-0.36%) + dividends paid over that year ($5.1B) ÷ market_cap_at(2025-06-30) ($94.2B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: 5.05%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($0) ÷ today's market cap ($130B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 0.00%2016-06 0.3%2026-06 0.0%-100.0% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $0 + TTM dividends $5.1B) ÷ today's market cap ($130B). Same caveat as the cash buyback yield.: 3.92%2016-06 3.0%2026-06 4.3%+41.4% over the window

Vs own 10Y history

P/E: 11th
P/S: 28th
P/B: 65th
P/FCF: 51st

Bar = where today’s multiple sits in BMY’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · windows as of 2026-09-11

-0.17%

-6.54%

-0.09%

+13.11%

YTD

+21.97%

+41.45%

+18.12%

Financial statements

Open full BMY financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	-8.44%	-0.65%
JNJ	Johnson & Johnson	+2.31%	-0.29%
ABBV	AbbVie Inc.	+3.36%	+0.83%
MRK	Merck & Co. Inc.	+8.28%	-0.54%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	-6.53%	-2.37%
TMO	Thermo Fisher Scientific Inc.	+1.13%	+1.10%
AMGN	Amgen Inc.	-8.80%	-1.34%
GILD	Gilead Sciences Inc.	+5.78%	-0.75%

Bristol-Myers Squibb Company (BMY) trades at $63.64 with a live price and an interactive chart covering 54+ years of daily price history, plus key valuation metrics. ChartRow also publishes BMY’s financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full BMY financial statements →

BMY — Bristol-Myers Squibb Company price, chart and key statistics